NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance - PubMed (original) (raw)

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

L M Hunt et al. Diabetes Care. 1997 Mar.

Abstract

Objective: This study examines NIDDM patients' attitudes toward insulin injections, the basis of these attitudes, and how they may affect patients' willingness to take insulin.

Research design and methods: Forty-four low-income Mexican American NIDDM patients were interviewed using open-ended in-depth interviewing techniques. Transcripts were analyzed using techniques of content analysis. Data classification was cross-checked in analysis conferences and through a second researcher coding 50% of the cases, comparing the results, then resolving any discrepancies.

Results: Patients' positive attitudes toward insulin focus on its efficacy and efficiency, the avoidance of complications, and feeling better and more energetic. Negative attitudes were much more frequently discussed and include "technical concerns": anxiety about the pain, proper techniques, and general hassles of taking injections; about hypoglycemic symptoms; and about insulin causing serious health problems; and "experimental concerns": sensing that the disease has progressed into a serious phase, that past treatment efforts have failed, and that the patient has not taken proper care. Attitudes were based on personal experience, observation, what others say, and interactions with health care professionals.

Conclusions: Results from the few published reports on NIDDM patients' attitudes about insulin from various cultural settings were consistent with our findings, indicating that these themes may be generally applicable to a wider population. It is recommended that health care providers take care to avoid unwitting promotion of negative attitudes toward insulin and actively elicit and respond to patient attitudes to reduce reluctance to take the medication.

PubMed Disclaimer

Cited by

Cultural Differences and Considerations When Initiating Insulin.
Rebolledo JA, Arellano R. Rebolledo JA, et al. Diabetes Spectr. 2016 Aug;29(3):185-90. doi: 10.2337/diaspect.29.3.185. Diabetes Spectr. 2016. PMID: 27574375 Free PMC article. No abstract available.
A systematic review of research into black and ethnic minority patients' views on self-management of type 2 diabetes.
Majeed-Ariss R, Jackson C, Knapp P, Cheater FM. Majeed-Ariss R, et al. Health Expect. 2015 Oct;18(5):625-42. doi: 10.1111/hex.12080. Epub 2013 May 27. Health Expect. 2015. PMID: 23710892 Free PMC article. Review.
A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
Hyllested-Winge J, Jensen KH, Rex J. Hyllested-Winge J, et al. Clin Drug Investig. 2010;30(10):643-74. doi: 10.2165/11584360-000000000-00000. Clin Drug Investig. 2010. PMID: 20701399 Review.
Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.
Baruah MP, Kalra S, Unnikrishnan AG, Raza SA, Somasundaram N, John M, Katulanda P, Shrestha D, Bantwal G, Sahay R, Latt TS, Pathan F. Baruah MP, et al. Indian J Endocrinol Metab. 2011 Apr;15(2):75-90. doi: 10.4103/2230-8210.81935. Indian J Endocrinol Metab. 2011. PMID: 21731863 Free PMC article.
A single-blind, placebo-controlled, dose-ranging trial of oral hepatic-directed vesicle insulin add-on to oral antidiabetic treatment in patients with type 2 diabetes mellitus.
Geho WB, Rosenberg LN, Schwartz SL, Lau JR, Gana TJ. Geho WB, et al. J Diabetes Sci Technol. 2014 May;8(3):551-9. doi: 10.1177/1932296814524871. Epub 2014 Feb 27. J Diabetes Sci Technol. 2014. PMID: 24876619 Free PMC article. Clinical Trial.

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance - PubMed (original) (raw)